Atossa Genetics Inc. (ATOS) announced Wednesday morning that it has entered into a contractual agreement with FedMed Inc., which will give FedMed's participating providers and its clients' members greater access to Atossa's tests.
Atossa Genetics has been climbing sharply since the open of trade Wednesday and is now up 2.10 at $8.70 on the highest volume in 3 months. The stock has risen above a one-month range and has set a new high.
For comments and feedback: editorial@rttnews.com